Search Results
Talaris Presentation at the 2022 Tandem Transplantation and Cellular Therapy Meeting
Talaris Presentation at the 2022 Cutting Edge of Transplantation (CEoT) Transplant Summit
Talaris Therapeutics’ Presentation for the Alport Syndrome Foundation Webinar
Innovation in Kidney Transplantation and Post-care (Talaris Therapeutics)
FCR001, an investigational cell therapy: Harnessing the power of immune tolerance in LDKT for HCP
Ch. 3: Protocol for Living Donor Kidney Transplant with FCR001, Designed to Induce Immune Tolerance
Ch. 6: FREEDOM-2 Phase 2 Trial with FCR001, Designed to Induce Immune Tolerance in LDKT Recipients
FREEDOM-1: A New Frontier in Living Donor Kidney Transplant
FREEDOM-3: A Quest for a Future Restored from Diffuse Scleroderma
Talaris Therapeutics
EBMT-EHA CAR T-cell highlights: new indications, new CAR-Ts & the microbiota’s impact on outcomes
Future developments in targeted cell therapies for autoimmune diseases
